FIELD: medicine, cardiology.
SUBSTANCE: the complex of medicinal therapy includes nibentane to be injected at the dosage of 0.125 mg/kg intravenously. Moreover, one should pre-inject magnesium sulfate solution at the dosage of 2.5 g about 10-15 min before nibentane injection. The innovation provides quick restoration of sinus rhythm in case of no therapeutic complications observed.
EFFECT: higher efficiency of therapy.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ATRIAL FIBRILLATION | 2020 |
|
RU2728715C1 |
| METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
| METHOD FOR PREVENTION OF RECURRENT ATRIAL FIBRILLATION FOLLOWING CARDIOSURGICAL OPERATIONS | 2014 |
|
RU2567920C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| METHOD FOR SINUS RHYTHM RESTORATION IN ATRIAL FLUTTER TYPE 1 | 2010 |
|
RU2448698C2 |
| METHOD FOR TREATING PERSISTING FORM OF ATRIAL FIBRILLATION | 2006 |
|
RU2320328C2 |
| METHOD FOR TREATMENT OF CARDIAC RHYTHM DISORDER | 1991 |
|
RU2008903C1 |
| AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
| METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
| METHOD FOR INDIVIDUAL SELECTION OF SUPPORTING DOSE OF LEVOSIMENDAN FOR TREATING ACUTE HEART FAILURE IN ELDERLY PATIENTS IN ACUTE PHASE OF MYOCARDIAL INFARCTION | 2015 |
|
RU2601666C1 |
